Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 30, 2025 Filed Jun 2, 2025 23:27 UTC |
Ramasastry SairaDirector
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $4.94 | $0.00 |
DisclosureSEC source: 0001628280-25-028898 · wk-form4_1748906840.xml · derivative · entry 2 Ramasastry Saira · CIK 0001547959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2035-05-29 F3 · shares: The shares subject to the stock option will vest and become exercisable in full on May 30, 2026. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 23:27 UTC |
Ramasastry SairaDirector
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-028898 · wk-form4_1748906840.xml · nonDerivative · entry 1 Ramasastry Saira · CIK 0001547959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,619 F1 · kind: Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan. F2 · shares: The RSUs will vest in full on May 30, 2026. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 23:22 UTC |
MORE ROBERT JDirector
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $4.94 | $0.00 |
DisclosureSEC source: 0001628280-25-028894 · wk-form4_1748906520.xml · derivative · entry 3 MORE ROBERT J · CIK 0001207792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2035-05-29 F4 · shares: The shares subject to the stock option will vest and become exercisable in full on May 30, 2026. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 23:22 UTC |
MORE ROBERT JDirector
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-028894 · wk-form4_1748906520.xml · nonDerivative · entry 1 MORE ROBERT J · CIK 0001207792 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,683 F1 · kind: Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan. F2 · shares: The RSUs will vest in full on May 30, 2026. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 23:26 UTC |
Napolitano JanetDirector
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $4.94 | $0.00 |
DisclosureSEC source: 0001628280-25-028896 · wk-form4_1748906763.xml · derivative · entry 3 Napolitano Janet · CIK 0001821008 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2035-05-29 F5 · shares: The shares subject to the stock option will vest and become exercisable in full on May 30, 2026. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 23:26 UTC |
Napolitano JanetDirector
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-028896 · wk-form4_1748906763.xml · nonDerivative · entry 1 Napolitano Janet · CIK 0001821008 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,616 F1 · kind: Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan. F2 · shares: The RSUs will vest in full on May 30, 2026. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 23:20 UTC |
Hatfield Jeffrey S.Director
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $4.94 | $0.00 |
DisclosureSEC source: 0001628280-25-028892 · wk-form4_1748906445.xml · derivative · entry 2 Hatfield Jeffrey S. · CIK 0001609879 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2035-05-29 F3 · shares: The shares subject to the stock option will vest and become exercisable in full on May 30, 2026. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 23:20 UTC |
Hatfield Jeffrey S.Director
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-028892 · wk-form4_1748906445.xml · nonDerivative · entry 1 Hatfield Jeffrey S. · CIK 0001609879 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,806 F1 · kind: Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan. F2 · shares: The RSUs will vest in full on May 30, 2026. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 23:19 UTC |
Farid RamyDirector
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $4.94 | $0.00 |
DisclosureSEC source: 0001628280-25-028890 · wk-form4_1748906357.xml · derivative · entry 2 Farid Ramy · CIK 0001797707 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2035-05-29 F3 · shares: The shares subject to the stock option will vest and become exercisable in full on May 30, 2026. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 23:19 UTC |
Farid RamyDirector
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-028890 · wk-form4_1748906357.xml · nonDerivative · entry 1 Farid Ramy · CIK 0001797707 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 F1 · kind: Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan. F2 · shares: The RSUs will vest in full on May 30, 2026. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 23:17 UTC |
BISCHOFBERGER NORBERT WDirector
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $4.94 | $0.00 |
DisclosureSEC source: 0001628280-25-028888 · wk-form4_1748906238.xml · derivative · entry 2 BISCHOFBERGER NORBERT W · CIK 0001190273 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2035-05-29 F3 · shares: The shares subject to the stock option will vest and become exercisable in full on May 30, 2026. Read SEC document |
| May 30, 2025 Filed Jun 2, 2025 23:17 UTC |
BISCHOFBERGER NORBERT WDirector
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-028888 · wk-form4_1748906238.xml · nonDerivative · entry 1 BISCHOFBERGER NORBERT W · CIK 0001190273 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 F1 · kind: Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan. F2 · shares: The RSUs will vest in full on May 30, 2026. Read SEC document |
| April 03, 2025 Filed Apr 4, 2025 20:23 UTC |
De Backer MarianneDirector · Chief Executive Officer
|
SaleCommon Stock | 79,712 | $5.95 | $474,238.57 |
DisclosureSEC source: 0001628280-25-016800 · wk-form4_1743798213.xml · nonDerivative · entry 1 De Backer Marianne · CIK 0001797819 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 769,505 F1 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| February 26, 2025 Filed Feb 27, 2025 17:39 UTC |
de Verneuil VaninaEVP and General Counsel
|
SaleCommon Stock | 7,373 | $9.14 | $67,402.49 |
DisclosureSEC source: 0001628280-25-008499 · wk-form4_1740677961.xml · nonDerivative · entry 1 de Verneuil Vanina · CIK 0002036234 · EVP and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,460 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.03 to $9.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 20:37 UTC |
Sabatini BrentSVP, Chief Accounting Officer
|
SaleCommon Stock | 1,562 | $9.45 | $14,766.21 |
DisclosureSEC source: 0001628280-25-007696 · wk-form4_1740515835.xml · nonDerivative · entry 2 Sabatini Brent · CIK 0002037272 · SVP, Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,627 F2 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 15:43 UTC |
HANLY ANN M.EVP & Chief Technology Officer
|
SaleCommon Stock | 14,168 | $9.45 | $133,935.77 |
DisclosureSEC source: 0001628280-25-007706 · wk-form4_1740516204.xml · nonDerivative · entry 1 HANLY ANN M. · CIK 0001854528 · EVP & Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,901 F1 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 20:44 UTC |
SCANGOS GEORGE ADirector
|
SaleCommon Stock | 10,056 | $9.45 | $95,063.39 |
DisclosureSEC source: 0001628280-25-007708 · wk-form4_1740516289.xml · nonDerivative · entry 1 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 698,239 F1 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 20:36 UTC |
De Backer MarianneDirector · Chief Executive Officer
|
SaleCommon Stock | 16,122 | $9.45 | $152,407.71 |
DisclosureSEC source: 0001628280-25-007693 · wk-form4_1740515751.xml · nonDerivative · entry 2 De Backer Marianne · CIK 0001797819 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 849,217 F2 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 20:34 UTC |
de Verneuil VaninaEVP and General Counsel
|
SaleCommon Stock | 5,140 | $9.45 | $48,590.48 |
DisclosureSEC source: 0001628280-25-007690 · wk-form4_1740515688.xml · nonDerivative · entry 2 de Verneuil Vanina · CIK 0002036234 · EVP and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,833 F2 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 20:37 UTC |
Sabatini BrentSVP, Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $9.57 | $0.00 |
DisclosureSEC source: 0001628280-25-007696 · wk-form4_1740515835.xml · derivative · entry 3 Sabatini Brent · CIK 0002037272 · SVP, Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2035-02-21 F3 · derivative.exercise_date: 25% of the shares subject to the stock option vest and become exercisable on February 22, 2026, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 20:37 UTC |
Sabatini BrentSVP, Chief Accounting Officer
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007696 · wk-form4_1740515835.xml · nonDerivative · entry 1 Sabatini Brent · CIK 0002037272 · SVP, Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,189 F1 · kind: Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 20:41 UTC |
O'Byrne JasonEVP & Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $9.57 | $0.00 |
DisclosureSEC source: 0001628280-25-007703 · wk-form4_1740516057.xml · derivative · entry 2 O'Byrne Jason · CIK 0001871145 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2035-02-21 F2 · derivative.exercise_date: 25% of the shares subject to the stock option vest and become exercisable on February 22, 2026, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 20:41 UTC |
O'Byrne JasonEVP & Chief Financial Officer
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007703 · wk-form4_1740516057.xml · nonDerivative · entry 1 O'Byrne Jason · CIK 0001871145 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,000 F1 · kind: Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 20:39 UTC |
Eisner MarkEVP and Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $9.57 | $0.00 |
DisclosureSEC source: 0001628280-25-007699 · wk-form4_1740515940.xml · derivative · entry 2 Eisner Mark · CIK 0001834161 · EVP and Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2035-02-21 F2 · derivative.exercise_date: 25% of the shares subject to the stock option vest and become exercisable on February 22, 2026, and the remainder vest in 36 equal monthly installments thereafter. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 20:39 UTC |
Eisner MarkEVP and Chief Medical Officer
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007699 · wk-form4_1740515940.xml · nonDerivative · entry 1 Eisner Mark · CIK 0001834161 · EVP and Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,000 F1 · kind: Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 20:36 UTC |
De Backer MarianneDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 480,000 | $0.00 Strike: $9.57 | $0.00 |
DisclosureSEC source: 0001628280-25-007693 · wk-form4_1740515751.xml · derivative · entry 4 De Backer Marianne · CIK 0001797819 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 480,000 Underlying: Common Stock · 480,000 shares Expires 2035-02-21 F4 · derivative.exercise_date: 25% of the shares subject to the stock option vest and become exercisable on February 22, 2026, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 20:36 UTC |
De Backer MarianneDirector · Chief Executive Officer
|
GrantCommon Stock | 240,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007693 · wk-form4_1740515751.xml · nonDerivative · entry 1 De Backer Marianne · CIK 0001797819 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 865,339 F1 · kind: Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 20:34 UTC |
de Verneuil VaninaEVP and General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $9.57 | $0.00 |
DisclosureSEC source: 0001628280-25-007690 · wk-form4_1740515688.xml · derivative · entry 3 de Verneuil Vanina · CIK 0002036234 · EVP and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2035-02-21 F3 · derivative.exercise_date: 25% of the shares subject to the stock option vest and become exercisable on February 22, 2026, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 20:34 UTC |
de Verneuil VaninaEVP and General Counsel
|
GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-007690 · wk-form4_1740515688.xml · nonDerivative · entry 1 de Verneuil Vanina · CIK 0002036234 · EVP and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 91,973 F1 · kind: Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 00:11 UTC |
SCANGOS GEORGE ADirector
|
SaleCommon Stock | 10,964 | $9.81 | $107,575.48 |
DisclosureSEC source: 0001628280-25-006516 · wk-form4_1740010306.xml · nonDerivative · entry 1 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 708,295 F1 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 23:41 UTC |
Sabatini BrentSVP, Chief Accounting Officer
|
SaleCommon Stock | 1,562 | $9.15 | $14,291.36 |
DisclosureSEC source: 0001628280-25-005864 · wk-form4_1739576505.xml · nonDerivative · entry 1 Sabatini Brent · CIK 0002037272 · SVP, Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,189 F1 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. F2 · balance_after: Reflects ownership after acquisition by the reporting person on November 29, 2024 of 1,312 shares of common stock pursuant to the Issuer's employee stock purchase program. Read SEC document |
| January 08, 2025 Filed Jan 9, 2025 01:03 UTC |
SATO VICKI LDirector
|
SaleCommon Stock | 10,960 | $12.52 | $137,219.20 |
DisclosureSEC source: 0001628280-25-000994 · wk-form4_1736384620.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,312,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 29, 2024. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 20:35 UTC |
de Verneuil VaninaEVP and General Counsel
|
SaleCommon Stock | 76 | $8.22 | $624.73 |
DisclosureSEC source: 0001628280-24-049897 · wk-form4_1733344540.xml · nonDerivative · entry 1 de Verneuil Vanina · CIK 0002036234 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,973 F1 · kind: The shares were sold pursuant to a sale instruction entered into on May 28, 2024, whereby shares purchased on November 29, 2024 pursuant to the Issuer's employee stock purchase program were automatically sold six months after the instruction date. F2 · balance_after: Reflects ownership after acquisition by the reporting person on November 29, 2024 of 76 shares of common stock pursuant to the Issuer's employee stock purchase program, and sale of such shares on December 2, 2024. Read SEC document |
| November 15, 2024 Filed Nov 18, 2024 18:36 UTC |
O'Byrne JasonEVP & Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $8.64 | $0.00 |
DisclosureSEC source: 0001628280-24-048230 · wk-form4_1731954966.xml · derivative · entry 2 O'Byrne Jason · CIK 0001871145 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2034-11-14 F2 · derivative.exercise_date: 25% of the shares subject to the stock option vest and become exercisable on November 15, 2025, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 15, 2024 Filed Nov 18, 2024 18:36 UTC |
O'Byrne JasonEVP & Chief Financial Officer
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-048230 · wk-form4_1731954966.xml · nonDerivative · entry 1 O'Byrne Jason · CIK 0001871145 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,000 F1 · acquired: Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 00:20 UTC |
de Verneuil VaninaEVP and General Counsel
|
SaleCommon Stock | 4,397 | $10.11 | $44,453.67 |
DisclosureSEC source: 0001628280-24-046462 · wk-form4_1731025248.xml · nonDerivative · entry 1 de Verneuil Vanina · CIK 0002036234 · EVP and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,973 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2024. Read SEC document |
| November 05, 2024 Filed Nov 5, 2024 22:51 UTC |
de Verneuil VaninaEVP and General Counsel
|
SaleCommon Stock | 2,347 | $9.47 | $22,225.15 |
DisclosureSEC source: 0001628280-24-045387 · wk-form4_1730847101.xml · nonDerivative · entry 2 de Verneuil Vanina · CIK 0002036234 · EVP and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,370 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.30 to $9.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 22:51 UTC |
de Verneuil VaninaEVP and General Counsel
|
SaleCommon Stock | 1,403 | $7.20 | $10,107.07 |
DisclosureSEC source: 0001628280-24-045387 · wk-form4_1730847101.xml · nonDerivative · entry 1 de Verneuil Vanina · CIK 0002036234 · EVP and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,717 F1 · kind: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. Read SEC document |
| October 23, 2024 Filed Oct 24, 2024 20:26 UTC |
SCANGOS GEORGE ADirector
|
OtherCommon Stock | 598,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-043632 · wk-form4_1729801556.xml · nonDerivative · entry 4 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,151,730 F1 · kind: Transfer without consideration for tax planning purposes. F4 · ownership.nature: The shares are held in the name of Leslie Wilson 2023 Annuity Trust, of which the reporting person and his spouse are Trustees. Read SEC document |
| October 23, 2024 Filed Oct 24, 2024 20:26 UTC |
SCANGOS GEORGE ADirector
|
OtherCommon Stock | 598,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-043632 · wk-form4_1729801556.xml · nonDerivative · entry 3 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 598,270 F1 · kind: Transfer without consideration for tax planning purposes. F3 · ownership.nature: The shares are held by the spouse of the reporting person. Read SEC document |
| October 23, 2024 Filed Oct 24, 2024 20:26 UTC |
SCANGOS GEORGE ADirector
|
OtherCommon Stock | 598,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-043632 · wk-form4_1729801556.xml · nonDerivative · entry 2 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,151,730 F1 · kind: Transfer without consideration for tax planning purposes. F2 · ownership.nature: The shares are held in the name of the George A Scangos 2023 Annuity Trust, of which the reporting person and his spouse are Trustees. Read SEC document |
| October 23, 2024 Filed Oct 24, 2024 20:26 UTC |
SCANGOS GEORGE ADirector
|
OtherCommon Stock | 598,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-043632 · wk-form4_1729801556.xml · nonDerivative · entry 1 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 719,259 F1 · kind: Transfer without consideration for tax planning purposes. Read SEC document |
| September 09, 2024 Filed Sep 10, 2024 20:28 UTC |
Napolitano JanetDirector
|
SaleCommon Stock | 12,190 | $7.80 | $95,032.02 |
DisclosureSEC source: 0001628280-24-040035 · wk-form4_1726000121.xml · nonDerivative · entry 1 Napolitano Janet · CIK 0001821008 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,616 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.49 to $7.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 20:40 UTC |
Eisner MarkEVP and Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $9.37 | $0.00 |
DisclosureSEC source: 0000950170-24-083951 · ownership.xml · derivative · entry 2 Eisner Mark · CIK 0001834161 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2034-07-14 F2 · derivative.exercise_date: 25% of the shares subject to the stock option vest and become exercisable on July 15, 2025, and the remainder vest in 36 equal monthly installments thereafter. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 20:40 UTC |
Eisner MarkEVP and Chief Medical Officer
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-083951 · ownership.xml · nonDerivative · entry 1 Eisner Mark · CIK 0001834161 · EVP and Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 F1 · kind: Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan. Read SEC document |
| June 12, 2024 Filed Jun 12, 2024 20:00 UTC |
De Backer MarianneDirector · Chief Executive Officer
|
OtherCommon Stock | 53,118 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-027797 · wk-form4_1718222423.xml · nonDerivative · entry 2 De Backer Marianne · CIK 0001797819 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 53,118 F1 · kind: Transfer without consideration for tax planning purposes. F2 · ownership.nature: The shares are held in the name of the Ureel-De Backer Family Trust, of which the reporting person and her spouse are Trustees. Read SEC document |
| June 12, 2024 Filed Jun 12, 2024 20:00 UTC |
De Backer MarianneDirector · Chief Executive Officer
|
OtherCommon Stock | 53,118 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-027797 · wk-form4_1718222423.xml · nonDerivative · entry 1 De Backer Marianne · CIK 0001797819 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625,339 F1 · kind: Transfer without consideration for tax planning purposes. Read SEC document |
| June 11, 2024 Filed Jun 12, 2024 16:21 UTC |
Ramasastry SairaDirector
|
SaleCommon Stock | 4,000 | $10.95 | $43,789.20 |
DisclosureSEC source: 0001628280-24-027760 · wk-form4_1718209307.xml · nonDerivative · entry 1 Ramasastry Saira · CIK 0001547959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,619 Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 16:18 UTC |
Sigal Charles ElliottDirector
|
GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $10.39 | $0.00 |
DisclosureSEC source: 0001628280-24-026221 · wk-form4_1717431521.xml · derivative · entry 3 Sigal Charles Elliott · CIK 0001661908 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2034-05-29 Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 16:18 UTC |
Sigal Charles ElliottDirector
|
GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-026221 · wk-form4_1717431521.xml · nonDerivative · entry 1 Sigal Charles Elliott · CIK 0001661908 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,806 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.